A 3-fold higher iron content was detected in HER2-overexpressing BT474 breast cancer xenografts over low HER2-expressing SKOV3 ovarian cancer xenografts, and magnetite retention in BT474 xenografts correlated with stable tumor regression [372]. Here, ERBB2 is linked to breast cancer.